Bio Farma Induk Holding BUMN Pharmacy, with its subsidiaries Kimia Farma and Indofarma, in collaboration with Merck Shar...
Toyo Ink SC Holdings, the parent company of Japan-based specialty chemicals manufacturer Toyo Ink Group, has concluded...
Zuellig Pharma, one of the largest healthcare services groups in Asia, has entered into an agreement with global biophar...
What are the key opportunities and challenges for APAC vaccine manufacturers in adopting and utilising mRNA technology?&...
GC Biopharma, a South Korean biopharmaceutical company, has announced that its quadrivalent flu vaccine called GC F...
GSK Singapore commemorated the groundbreaking ceremony for its S$343 million state-of-the-art vaccines facility at Tuas ...
Lifera, a biopharmaceutical company in Saudi Arabia together with French multinational pharmaceutical and healthcar...
South Korea-based biotech firm SK bioscience has signed a Memorandum of Understanding (MoU) with the Government Pha...
British firm GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHL...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...
The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in r...
Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced th...
South Korea-based International Vaccine Institute (IVI) and Institut Pasteur de Dakar (IPD) in West Africa, have signed ...
According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...
SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...
For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...
South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...
Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...
